Gene · 6708
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BRAF V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes. | Mol Cancer Ther | 2021 | 33722853 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of combined small cell lung cancer. | Transl Lung Cancer Res | 2021 | 33718010 | PubTator, text mining | PubMed |
| A novel panel based on immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinoma. | Aging (Albany NY) | 2021 | 33714200 | PubTator, text mining | PubMed |
| Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia. | Front Oncol | 2021 | 33708624 | PubTator, text mining | PubMed |
| Identification of a De Novoc.1000delA ANK1 mutation associated to hereditary spherocytosis in a neonate with Coombs-negative hemolytic jaundice-case reports and review of the literature. | BMC Med Genomics | 2021 | 33706756 | PubTator, text mining | PubMed |
| Rare anemias in adolescents. | Acta Biomed | 2021 | 33682847 | PubTator, text mining | PubMed |
| The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance. | Int J Mol Sci | 2021 | 33672223 | PubTator, text mining | PubMed |
| Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. | J Pers Med | 2021 | 33672117 | PubTator, text mining | PubMed |
| Human Placenta Exosomes: Biogenesis, Isolation, Composition, and Prospects for Use in Diagnostics. | Int J Mol Sci | 2021 | 33671527 | PubTator, text mining | PubMed |
| Phase 1 cohort expansion study of LY3023414, a dual PI3K/mTOR inhibitor, in patients with advanced mesothelioma. | Invest New Drugs | 2021 | 33660194 | PubTator, text mining | PubMed |
| Programmed cell death-ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics. | J Gastroenterol Hepatol | 2021 | 33656759 | PubTator, text mining | PubMed |
| Transcription factor competition at the γ-globin promoters controls hemoglobin switching. | Nat Genet | 2021 | 33649594 | PubTator, text mining | PubMed |
| Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung Cancer. | Adv Sci (Weinh) | 2021 | 33643802 | PubTator, text mining | PubMed |
| CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer. | Sci Rep | 2021 | 33633150 | PubTator, text mining | PubMed |
| Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer. | BMC Urol | 2021 | 33632199 | PubTator, text mining | PubMed |
| Clinical manifestation and phenotypic analysis of novel gene mutation in 28 Chinese children with hereditary spherocytosis. | Mol Genet Genomic Med | 2021 | 33620149 | PubTator, text mining | PubMed |
| 20S proteasomes secreted by the malaria parasite promote its growth. | Nat Commun | 2021 | 33608523 | PubTator, text mining | PubMed |
Binding of the human antioxidation protein α1-microglobulin (A1M) to heparin and heparan sulfate. Mapping of binding site, molecular and functional characterization, and co-localization in vivo and in vitro. | Redox Biol | 2021 | 33607500 | PubTator, text mining | PubMed |
| Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma. | BMC Cancer | 2021 | 33579226 | PubTator, text mining | PubMed |
| Novel mechanism of hereditary pyropoikilocytosis phenotype due to co-inheritance of β globin and α spectrin mutations. | Am J Hematol | 2021 | 33556202 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/papers?page=33